Abstract:Jessica S Staempfli, 1 Melanie Kistler-Fischbacher, 2 Jan Gewiess, 3 Johannes Dominik Bastian, 3 Anna K Eggimann 4 1 Medical Faculty, University of Bern, Bern, Switzerland; 2 Centre on Aging and Mobility, Department of Geriatrics and Aging Research, University of Zurich, Zurich, Switzerland; 3 Department of Orthopaedic Surgery and Traumatology, Inselspital, Bern University Hospital, University of Bern, Bern, 3010, Switzerland; 4 Department of Geriatrics, Inselspital, Bern University Hospital, and University of Bern, Bern, 3010, Switzerland Correspondence: Anna K Eggimann, Department of Geriatrics, Inselspital, Bern University Hospital University of Bern, Freiburgstrasse 40, Bern, CH-3010, Switzerland, Tel +41 31 632 54 89, Email Purpose: Muscle ultrasound has emerged as a promising method in the diagnostic work-up of sarcopenia. The objective of this scoping review was to explore the validity of muscle ultrasound against the latest sarcopenia definitions among older adults. Methods: We adhered to the PRISMA guidelines for scoping reviews. A systematic search of databases was performed by two independent reviewers. All articles comparing the performance of ultrasound to an internationally acknowledged sarcopenia definition among older adults (≥ 60 years) and published between 2019/01/01 (the year updated sarcopenia definitions were introduced) and 2023/11/15 were included. Data were extracted and collated by muscle and muscle parameters. Results: Out of 2290 articles screened, six studies comprising 24 validity tests among a total of 1619 older adults (mean age 74.1 years, 52.2% female) were included. The validity tests investigated the rectus femoris (n = 7), biceps brachii (n = 5), gastrocnemius medialis (n = 4), tibialis anterior (n = 4), soleus (n = 3), and rectus abdominis (n = 1). The parameter muscle thickness (MT) (n = 14) was most commonly measured. The latest European and Asian sarcopenia definitions (EWGSOP2, AWGS2) were applied as reference standards in four validity tests each. None of the studies used the Sarcopenia Definition and Outcome Consortium (SDOC) criteria. The highest area under the curve AUC (0.92, 95% confidence interval [CI] 0.89– 0.94) was found for the muscle thickness of the rectus femoris muscle. Due to substantial heterogeneity among the studies, pooling of data using a meta-analytic approach was not feasible. Conclusion: Limited number of studies have examined the validity of muscle ultrasound for diagnosing sarcopenia based on recent definitions among older adults. Thereby, muscle thickness of the rectus femoris showed promising results regarding validity. Further studies are needed to investigate the validity of key muscles and to validate muscle ultrasound among older hospitalized patients. Keywords: geriatric assessment, muscle thickness, cross-sectional area, rectus femoris, POCUS, SARCUS, EWGSOP, AWGS, SDOC Sarcopenia is an age-related disease resulting in the loss of skeletal muscle mass, muscle function, and performance. 1 Its causes are multifactorial, including disuse, chronic disease, inflammation, mitochondrial dysfunction, and nutritional deficiencies. 2 The prevalence of sarcopenia ranges from 1% to 55%, influenced by factors such as the clinical setting, and sarcopenia definition (eg, diagnostic criteria, cut-off points). 3,4 Sarcopenia is associated with adverse clinical outcomes, such as functional decline, disability, falls, hospitalization, and mortality. 5–7 To mitigate these poor outcomes, early diagnosis and targeted interventions like resistance training are actively pursued. 8,9 In the diagnostic work-up of sarcopenia, muscle mass is recognized as a key criterion. 10 Over the last years, ultrasound has been increasingly used to measure muscle mass, taking advantage of its clinical feasibility and cost-efficiency. 11,12 Furthermore, ultrasound serves as a practical and noninvasive tool without radiation, making it applicable in community, hospital, and nursing home settings. 13 In various medical domains, particularly critical care, point-of-care ultrasound (POCUS) has established itself as a reliable diagnostic method for predicting adverse outcomes. 14 Notably, the working group on ultrasound in sarcopenia (SARCUS) has recently emphasized the need to standardize muscle ultrasound, advocating for its increased utilization in the assessment of sarcopenia. 11 However, evidence on the validity of muscle ultrasound to diagnose sarcopenia among older adults is limited. 15 A systematic review published in 2017 showed that ultrasound is a reliable and valid tool for the assess -Abstract Truncated-

Pitfalls in the measurement of muscle mass: a need for a reference standard

Sarcopenia: revised European consensus on definition and diagnosis

Diagnostic Criteria and Measurement Techniques of Sarcopenia: A Critical Evaluation of the Up-to-Date Evidence

State of the art of quantitative measurement of sarcopenia

The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia

Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis

Assessment of Skeletal Muscle Mass in Older People: Comparison Between 2 Anthropometry-Based Methods and Dual-Energy X-ray Absorptiometry

The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses

Sarcopenia: how to measure, when and why

Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium

New Perspectives for Low Muscle Mass Quantity/Quality Assessment in Probable Sarcopenic Older Adults: An Exploratory Analysis Study

Diagnostic Criteria and Clinical Outcomes in Sarcopenia Research: A Literature Review

Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand

The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)

Sarcopenia: no consensus, no diagnostic criteria, and no approved indication-How did we get here?

Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force

Establishing an Operational Definition of Sarcopenia in Australia and New Zealand: Delphi Method Based Consensus Statement

On the Definition of Sarcopenia in the Presence of Aging and Obesity—Initial Results from UK Biobank

Sarcopenia: an overview

The Validity of Muscle Ultrasound in the Diagnostic Workup of Sarcopenia Among Older Adults: A Scoping Review